Straitstimes.com header logo

Choose edition

Search

singapore

asia

world

opinion

life

business

sport

Visual

Podcasts

SPH Rewards

STClassifieds

Paid press releases

Advertise with us

FAQs

Contact us

 

Healthcare

Obamacare health subsidy to end as US Senate rejects duelling remedies 

The Democratic bill aims to extend Covid-era subsidies for three years, while the Republican bill would have sent up to US$1,500 (S$1,940) to individuals earning less than 700 per cent of federal poverty level.
The Democratic bill aims to extend Covid-era subsidies for three years, while the Republican bill would have sent up to US$1,500 (S$1,940) to individuals earning less than 700 per cent of federal poverty level.

Forum: Access to public healthcare a key reason for changes to IP riders

Countries should repurpose fiscal policies to weather future challenges: President Tharman

President Tharman Shanmugaratnam speaking at a lecture at the Massachusetts Institute of Technology Sloan School of Management on Dec 9.
President Tharman Shanmugaratnam speaking at a lecture at the Massachusetts Institute of Technology Sloan School of Management on Dec 9.

Forum: Cost matters in healthcare, but so does timeliness

Vertex’s gene therapy shows promise in younger children with blood disorders

Gene therapy Casgevy is based on CRISPR gene editing technology, which uses molecular "scissors" to trim faulty parts of genes.
Gene therapy Casgevy is based on CRISPR gene editing technology, which uses molecular "scissors" to trim faulty parts of genes.

Singapore Paincare privatisation bid fails as offeror fails to meet conditions by deadline

Catalist-listed Singapore Paincare had in May received a privatisation offer of $0.16 per share from Advance Bridge Healthcare.
Catalist-listed Singapore Paincare had in May received a privatisation offer of $0.16 per share from Advance Bridge Healthcare.

‘Superbugs’ surge to record levels in South Korea, with infections near 45,000

The World Health Organisation classified anti-microbial resistance as a top global public health threat in 2019.
The World Health Organisation classified anti-microbial resistance as a top global public health threat in 2019.

ADB, World Bank launch Pacific islands projects under new cofinancing model

The World Bank logo is seen at the 2023 Spring Meetings of the World Bank Group and the International Monetary Fund in Washington, U.S., April 13, 2023. REUTERS/Elizabeth Frantz
The World Bank logo is seen at the 2023 Spring Meetings of the World Bank Group and the International Monetary Fund in Washington, U.S., April 13, 2023. REUTERS/Elizabeth Frantz

New $21m research collaboration to develop treatments for eye diseases

azsonic03 - ST20251203_202527200202. Hester Tan. The Singapore Eye Research Institute and Santen Pharmaceutical will partner on the Santen-SERI Open Innovation Center (SONIC) 2.0, a S$21 million collaboration focusing on glaucoma, ocular surface disease, presbyopia and myopia and advance novel therapeutics that for unmet clinical needs at SNEC Auditorium on 3 December 2025

Top row: (L) Prof Thomas Coffman, Dean of Duke-NUS Medical School, Miss Rie Nakajima, Director of the Board, Chief Operating Officer, Santen and Prof Aung Tin, CEO, Singapore National Eye Centre

Bottom Row: (L) Prof Jodhbir Mehta, Director, Singapore Eye Research Institute and Dr Reza Haque, Head of Ophthalmology Innovation Center, Santen

ST PHOTO: HESTER TAN
azsonic03 - ST20251203_202527200202. Hester Tan. The Singapore Eye Research Institute and Santen Pharmaceutical will partner on the Santen-SERI Open Innovation Center (SONIC) 2.0, a S$21 million collaboration focusing on glaucoma, ocular surface disease, presbyopia and myopia and advance novel therapeutics that for unmet clinical needs at SNEC Auditorium on 3 December 2025

Top row: (L) Prof Thomas Coffman, Dean of Duke-NUS Medical School, Miss Rie Nakajima, Director of the Board, Chief Operating Officer, Santen and Prof Aung Tin, CEO, Singapore National Eye Centre

Bottom Row: (L) Prof Jodhbir Mehta, Director, Singapore Eye Research Institute and Dr Reza Haque, Head of Ophthalmology Innovation Center, Santen

ST PHOTO: HESTER TAN

Forum: IP rider changes aimed at retaining original purpose of protecting patients against large bills

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Privacy Policy

Need help? Reach us here.

Advertise with us

Download the app

Get unlimited access to exclusive stories and incisive insights from the ST newsroom
Subscribe Placeholder
MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2025 SPH Media Limited. All rights reserved.